Retail pharmacy operators and other health care providers recently were given a preview of the difficulties involved in implementing the findings of comparative effectiveness research, a science-based approach to evaluating the benefits and potential dangers of alternative forms of diagnosis and tre
With 2009 winding down, the time has come to list the most memorable events of the year in chain drug retailing. Herewith, seven such events: • The remaking of Walgreens.
The day before the Senate leadership unveiled an $848 billion bill that will be the focal point of the next phase of the health care reform debate, all of the members of Congress received a timely reminder about the importance of including measures to improve medication compliance in whatever legisl
The most significant development in chain drug retailing this year has been its willingness, finally, to begin to unleash the power of the pharmacist and the pharmacy that supports him.
Duane Reade, which will celebrate its 50th anniversary in 2010, is a fixture on the retail scene in New York City.
The first registration materials for the 2010 National Association of Chain Drug Stores Annual Meeting came in the mail last week.
Tom Ryan brings his customary concentration of thought and clarity of purpose to the issue of health care reform in an op-ed piece that recently appeared in The Washington Times.
CVS Caremark and Walgreens both opened their 7,000th drug store earlier this fall, within a week of each other. CVS’ milestone store opened in a suburb of St. Paul, while Walgreens’ landmark unveiling took place in the Coney Island section of Brooklyn, N.Y.
The commoditization of community pharmacy has come in for a good deal of criticism in recent years.
Earlier this month, Mike Bloom, CVS’ chief merchant, got a promotion.
Everywhere community pharmacy operators turn these days there seems to be a new challenge. Over the weekend, chain drug stores and other prescription drug providers began to feel the fallout from the reduction in average wholesale prices mandated by the settlement of a class-action lawsuit.
Chain drug retailing is changing more quickly and more dramatically than at any time in recent memory.
Retail pharmacy operators garnered a significant victory late last month when the state of Delaware agreed to rescind some of the cuts it had intended to make in reimbursements for prescriptions filled under the Medicaid program.
When Len DeMino retired earlier this month after over 50 years of service to the profession of community pharmacy, he closed the door on the golden era of chain drug retailing, an era he helped define. When DeMino began his career in 1958 as a pharmacist for Washington, D.C.
In a letter, Chain Drug Review‘s editor urges National Association of Chain Drug Stores chief executive Steve Anderson to tackle core issues for the association head on. Steve Anderson President and CEO NACDS 413 N. Lee St. Alexandria, Va.
Despite President Obama’s wish to have both chambers of Congress pass health care reform bills before the start of the August recess, it appeared almost certain that legislators would return home without acting.
